Gil Hakim, president of Israeli operations for Israeli company UroGen Pharma, holds vials containing...
Gil Hakim, president of Israeli operations for Israeli company UroGen Pharma, holds vials containing the company's RTGel, at the company's laboratory in Raanana, Israel, June 17, 2018. Picture taken June 17, 2018. REUTERS/Amir Cohen